COMMUNIQUÉS West-GlobeNewswire

Most Popular Legal Steroids for Muscle Building from CrazyBulk: Best Selling Steroid Alternatives for Muscle Growth and Cutting in 2025
08/09/2025
New York City, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Introduction: What are the best legal steroid alternatives for muscle growth and fat loss from Crazybulk’s supplement range. In 2025, demand for legal steroid [...]
Shiny Smile Veneers Surpasses 100,000 Smiles Transformed in 2025 as Demand for Lifestyle Dental Health Solutions Grows
08/09/2025
Shiny Smile Veneers, founded by practicing dentist Dr. Dean, has officially surpassed 100,000 customers in 2025. The milestone highlights the rising demand for affordable, custom-made removable veneers that combine [...]
Go North Hemp Forecasts 100% Year-Over-Year Revenue Growth in 2025, Strengthening Market Leadership in Next-Gen Hemp Ingredients
08/09/2025
TIGARD, Ore., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Go North Hemp, a U.S. wholesale supplier of hemp-derived ingredients, today announced it is on track to double annual revenue in 2025 versus 2024, supported by expanding [...]
RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025
08/09/2025
LOS ANGELES, Sept. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General Meeting of September 30, 2025
08/09/2025
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General Meeting of September 30, 2025 NANTES, France, September 8, 2025, 6p.m. CET – OSE Immunotherapeutics SA (ISIN: [...]
OSE Immunotherapeutics fait le point sur les procédures en cours avant l’Assemblée Générale Annuelle des actionnaires du 30 septembre 2025
08/09/2025
OSE Immunotherapeutics fait le point sur les procédures en cours avant l’Assemblée Générale Annuelle des actionnaires du 30 septembre 2025 NANTES, France – 8 septembre 2025, 18 heures – OSE Immunotherapeutics SA (ISIN: [...]
Press Release : Sequana Medical Announces New Share Capital Amount and New Number of Shares
08/09/2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 8 September 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the [...]
Idorsia highlights very low real-world abuse potential of DORA class for insomnia treatment at WSC 2025
08/09/2025
Analysis of the FAERS database shows that the real-world abuse potential of the DORA class is very low and markedly less than those seen for other scheduled and non-scheduled insomnia therapies Allschwil, Switzerland – [...]
BIO CEO John Crowley to Receive Prestigious Dennis K. Stone Award at BioNTX iC³® Summit
08/09/2025
DALLAS, Sept. 08, 2025 (GLOBE NEWSWIRE) -- BioNTX proudly announces that John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), has been named the 2025 recipient of the Dennis K. Stone Award [...]
Prenetics’ IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open Championship
08/09/2025
Aryna Sabalenka becomes first woman to defend US Open title in more than a decade AI-powered Aryna Sabalenka ad goes viral with 233M Instagram views and Times Square billboard during US Open IM8 achieves 300,000+ [...]
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity
08/09/2025
PD-L1xVEGF-A bispecific antibody pumitamig (BNT327/BMS986545) plus chemotherapy continues to show encouraging antitumor activity in patients with extensive-stage small cell lung cancer (”ES-SCLC”) , expanding evidence [...]
KFSHRC Launches Middle East’s First Smart Neuroscience Ward With Electromagnetic Shielding for Ultra-Precise Brain Monitoring
08/09/2025
RIYADH, Saudi Arabia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has inaugurated the Middle East’s first Smart Neuroscience Ward, a pioneering facility that [...]
Streamex Exchange Corp NASDAQ-BSGM Creates a Tokenized Yield-Bearing Gold Product Generating up-to 4% through Exclusive Partnership with Monetary Metals
08/09/2025
Partnership unlocks exclusive tokenization rights, a four percent (4%) annual yield target on physical bullion, revenue share tied to leasing volumes and the creation of a groundbreaking institutionalized asset [...]
BlueGenesLab Expands Genetic Panel to Include Three New GLP-1–Related Genes
08/09/2025
SCOTTSDALE, Ariz., Sept. 08, 2025 (GLOBE NEWSWIRE) -- BlueGenesLab , a precision genomics company headquartered in Scottsdale, Arizona, today announced the addition of three genes to its clinical testing panel that [...]
Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform
08/09/2025
WARREN, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today shared the risk-adjusted net present value (rNPV) estimate of $9 billion to $11 billion for TVGN [...]
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
08/09/2025
Long-Term Data Adds to the Growing Body of Evidence Supporting the Compelling Clinical Profile of Pombiliti® + Opfolda® PRINCETON, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today [...]
MediciNova Provides Shareholder Update on Key Developments
08/09/2025
LA JOLLA, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Journal of Healthcare Management Study Uncovers Critical Gaps in Hospital Employee Surveys Used to Assess Risk of Clinician Turnover, Unveiling Need for Atalan Platform
08/09/2025
Data found 12 times higher risk of turnover among nonresponding clinicians, revealing how nonresponse bias distorts survey results and emphasizing the need for objective data solutions Study co-authored by world- [...]
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
08/09/2025
Expands international footprint with entry into Asia-Pacific, building on recent CE Mark and UK approvals ATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making [...]

Pages